Overview

The Effect of BIIL 284 BS on Induced-sputum Variables in Patients With Bronchial Asthma

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study to evaluate the anti-inflammatory effect of BIIL 284 BS compared with placebo in patients with asthma
Phase:
Phase 2
Details
Lead Sponsor:
Boehringer Ingelheim